Hallucinations are transmodal and transdiagnostic phenomena, occurring across sensory modalities and presenting in psychiatric, neurodegenerative, neurological, and non-clinical populations. Despite their cross-category occurrence, little empirical work has directly compared between-group neural correlates of hallucinations.
Introduction
Hallucinations are transdiagnostic and transmodal perceptions of stimuli that do not exist in the physical world 1 .
They are prevalent in both psychiatric disorders, such as schizophrenia (60-80%) 2 and bipolar disorder (BD 10-23%) 3 , and neurodegenerative diseases, such as Parkinson's disease (PD; 22-38%) 4 , dementia with Lewy Bodies (DLB; 80%) 5 , and Alzheimer's disease (AD; 13-18%) 6 , as well as in other psychiatric and neurological disorders, and among the general population (4.5-12.7%) 7 . Irrespective of diagnosis, the presence of hallucinations marks an increased risk of adverse outcomes, such as reduced likelihood of recovery in schizophrenia 8 , more severe cognitive deficits in PD 9 , increased mortality in AD 10 , increased suicidal behaviour in adults with psychosis 11 , and transition to later mental illness in children and young adults 12, 13 . Although hallucinations are often distressing, they may also be benign or contribute to meaningful personal experiences 14, 15 .
Historically, hallucinations were considered a cardinal symptom of schizophrenia, but they are not pathognomic:
one-third of patients do not hallucinate 2 , and the experience is often heterogeneous among those who do 1 . This has been confirmed across clinical and non-clinical populations, revealing diverse phenomenology involving modality, content, affect, onset, and frequency 15, 16 . Inter-individual differences among hallucinations prompt a number of conceptual, mechanistic, and clinical questions: Does phenomenological heterogeneity translate into neurobiological plurality? How would this influence theoretical models of hallucinations and inform treatments? Does the epidemiological and experiential diversity of hallucinations reflect a continuum model, in which symptoms like hallucinations are distributed over a spectrum of individuals who do and do not meet criteria for mental illness, and thus arise from a common mechanism instantiated to different degrees of severity 17 ? Establishing the validity of this conceptual framework against alternatives is important for how we understand and treat hallucinations.
Despite the plurality of hallucinations, there is little empirical work comparing between-group neural correlates of hallucinations. Prior reviews and meta-analyses on the brain structural and functional correlates of hallucinations have generally limited their scope to a single diagnosis or modality [18] [19] [20] , or both [21] [22] [23] [24] [25] . Only two reviews have investigated hallucinations transdiagnostically or in more than one modality: one without quantitative meta-analytic comparison 26 , the other focussed on acute functional correlates of hallucinations 27 . Two meta-analyses have explored the structural correlates of hallucinations, but assessed correlates of hallucination severity rather than presence/absence, and limited their scope to auditory verbal hallucinations (AVH) in schizophrenia 23, 24 . We therefore planned meta-analyses to evaluate MRI-derived volumetric structural grey matter (GM) correlates of hallucination status across populations, complemented with a comprehensive review of other structural measures, including cortical thickness, gyrification, and structure-specific morphometrics. A significant issue in neuroimaging studies of hallucinations has been the lack of a clinical control group, thus confounding abnormalities specific to hallucination status with those of the broader phenotype. Equally challenging has been a tangled conceptual landscape, with numerous models proposed as cognitive or neurobiological accounts of auditory or visual hallucinations 5, 26, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] (Figure 1 ). Obtaining differentiating evidence is difficult as these models are not mutually exclusive, each drawing upon a similar repertoire of constituents, making it non-trivial to derive corresponding predictions 42 . However, specific morphological variation can differentiate patients who do and do not hallucinate 43 , indicating that structural MRI can provide insights into why individuals hallucinate.
Voxel-based morphometry (VBM) is a common method for unbiased, automated quantification of GM differences between groups. Conducting a meta-analysis of VBM studies is an objective approach to synthesize the extant literature and identify replicable findings 44 . Knowledge of neuroanatomical signatures of hallucinations present in certain populations and absent in others would clarify the continuum model and contribute towards a clearer neurobiological picture of the origins and mechanisms of hallucinations. Considering the cultural and historical influences on hallucination interpretation 14 , an organic model of hallucinations could moreover substantiate accurate diagnostic criteria. This meta-analysis and systematic review quantitatively compared people with and without hallucinations in terms of brain structure to identify the neuroanatomy related to the transdiagnostic presence of hallucinations.
Figure 1. Landscape of theoretical models of hallucinations.
The major cognitive, psychological, and neurobiological theories for auditory and visual hallucinations are depicted. Separate theories have been proposed to underlie auditory versus visual hallucinations, although they share many common themes. Different theories within each modality category are not mutually exclusive and may overlap in their predictions. Dotted lines delineate proposals of divisions between, extensions to, or limitations of current theories. Key references: Inner speech model 45 ; Intrusive memory hypothesis 28 ; Resting state hypothesis 29 ; Abnormal salience monitoring hypothesis 30 ; Expectation-perception model 31 ; Reality monitoring deficit theory, Dream imagery intrusion theory, Activation input modulation theory 36, 46 ; Disinhibition hypothesis 5 ; Perception and attention deficit model 32 ; Top-down bottom-up models 26, 33 ; Excitatory-inhibitory imbalance 34 ; Predictive processing accounts 35, 37 ; proposal of divide between self-monitoring accounts and spontaneous activity accounts for auditory verbal hallucinations (AVH) 38 ; proposal of subtypes for AVH 40 ; proposal for differential contribution of pharmacological subsystems to different types of AVH 41 ; commentary on need to address interaction between and hierarchy of different modalities of hallucinations 109 . VBM studies and studies using non-voxelwise structural MRI methods that otherwise matched inclusion criterion (b) were included in the systematic review.
Data analysis
Voxel-wise meta-analyses were undertaken using anisotropic effect-size seed-based d Mapping (AES-SDM;
https://www.sdmproject.com/) 48, 49 following recommended guidelines 44 (Supplementary S1). AES-SDM uses peak coordinates and effect sizes from primary studies to create maps of meta-analytic effect size and variance of the signed GM differences. Similar to other voxel-based meta-analytic methods 50 , loci from primary studies are estimated as smoothed spheres and meta-analytic maxima calculated by weighting the encompassed voxels 48 .
Additionally, AES-SDM incorporates the effect sign (increases or decreases) and the t-statistic associated with each peak, increasing both sensitivity and accuracy 48 . AES-SDM also allows inclusion of non-significant studies, reducing bias towards positive results. AES-SDM is detailed elsewhere (https://www.sdmproject.com/software/tutorial.pdf), and summarized in Supplementary S2.
Anticipating differences in mechanisms of hallucinations between psychiatric illnesses and neurodegenerative diseases based on distinctions in phenomenology, modality, prevalence 51 , and the significant participant age separation amongst primary studies (t(25) = 17.324, p<0.001), we performed a meta-analysis including schizophrenia, first episode schizophrenia (FES), first episode psychosis (FEP), and young adults at clinical risk for psychosis (at-risk mental state long-term, ARMS-LT), and BD, and a second of neurodegenerative disorders, including PD and AD. Of the 16 studies included in these two cross-sectional meta-analyses, three (see Table 1 ) did not make an explicit comparison between a hallucination (H) and no-hallucinations (NH) group, though the majority of patients in each group respectively either did or did not have hallucinations, and were therefore included 52-54 . A jackknife sensitivity analysis was performed on the meta-analyses to test reproducibility of significant brain regions by iteratively repeating the statistical analysis systematically excluding one study 55 . Finally, we formally assessed group differences between psychiatric and neurodegenerative hallucination meta-analyses using Monte Carlo randomizations to determine statistical significance 56 .
Role of the funding source
There was no funding source for this study. CR had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
The literature search identified 2259 articles from PubMed and 1785 from Web of Science, for a merged total of 3214 after duplicates were excluded ( Figure 2 ). 99 articles were selected for whole text retrieval after title/abstract screening. 16 studies met criteria for the meta-analyses 43,52-54,57-68 (see Table 1 for sample characteristics; Table 2 for analysis details and results summary) and 28 papers (18 psychiatric; 10 neurodegenerative) for the systematic review of other structural metrics comparing groups with and without hallucinations.
In patients with hallucinations, relative to those without, GM reductions were identified in the left insula, right inferior frontal gyrus (IFG), left anterior cingulate/paracingulate gyrus, and left middle temporal gyrus (MTG), while GM increases were observed in bilateral fusiform gyrus (Table 3, Figure 3 ). Significant decreases in GM were apparent in six brain regions in patients with hallucinations compared to those without: (1) Figure 3 ).
28 studies employed a regional and/or non-voxelwise approach to evaluate structural MRI data with respect to hallucination status: seven studies performed VBM restricted to predefined ROIs 43,61,69-73 , one performed sourcebased morphometry 74 , nine explored cortical thickness (CT) and/or surface area [75] [76] [77] [78] [79] [80] [81] [82] [83] , three investigated gyral/sulcal properties 43, 84, 85 , and 11 assessed structure-specific shape parameters 43, 81, 83, [86] [87] [88] [89] [90] [91] [92] [93] . Results are summarized in Tables 5-6 . Overall, findings were heterogeneous, with few direct replications. In schizophrenia, the most consistent findings were reductions in CT in the left or right temporal gyrus for patients with hallucinations compared to those without 75, 76, 94 , coincident with the reductions in GM in left MTG observed in the meta-analysis ( Figure 3 ). However, two studies reported increases in GM in temporal regions with hallucinations 88, 90 . Hallucinations in PD and DLB were characterized by distributed patterns of cortical thinning 81, 82 and related to hippocampal volume, though the direction of this association was mixed 81, 83 . Abbreviations: H: Hallucinations; NH: No hallucinations. *The jackknife sensitivity analysis tests the reproducibility of significant brain regions by iteratively repeating the statistical analysis, but systematically excluding one study from each replication 55 . Fractions show the number of study combinations in which the region was preserved out of the total number of dataset combinations. 
Discussion
Distinctive patterns of neuroanatomical alteration characterize hallucination status in patients with psychiatric and neurodegenerative diseases, with the former associated with fronto-temporal deficits and the latter with medial temporal, thalamic and occipital deficits. These results broadly align with prior meta-analyses investigating GM correlates of hallucination severity of AVH in schizophrenia 23, 24, 26 (Supplementary S3-4 ) and qualitative reviews on structural imaging studies of visual hallucinations (VH) in neurodegenerative illnesses 25, 96 . The distributed pattern of structural changes seen in both hallucination signatures is suggestive of impairment in the coordination of information flow. Indeed, AVH in schizophrenia has been associated with increased functional activation in the STG, insula, anterior cingulate, and pre/post central gyrus 21, 22 , reduced resting connectivity between default mode regions 97 , disruptions to the salience network 30 , and altered interactions between resting-state networks 97 . VH in PD have been associated with increased functional activity in the lingual gyrus, cuneus, and fusiform gyrus 27 , and hyperconnectivity in the default mode network 98 . Cortical thickness studies lend further support for divergent structural patterns, showing localized decreases in CT in temporal regions in schizophrenia spectrum disorders and more widespread decreases in dementia and PD.
We reviewed the brain structural abnormalities associated with hallucinations, yet how changes to the brain's topological substrate translate to changes in an individual's experiential landscape remain unknown. Our findings are consistent with multiple models of hallucinations ( Figure 1 ). For instance, volume loss in temporal regions could reflect the misattribution of inner speech to a non-self source (inner speech model) 45 , or relate to abnormalities in cortical feedback for predictive signal processing (predictive processing account) 99 , or could be the result (or cause) of heightened resting state activity in the auditory cortex (resting state hypothesis) 29 , or a combination of some or all of these mechanisms. That substantial heterogeneity was observed in ROI VBM hypothesis-driven studies further emphasizes the limits of current theories.
Our meta-analyses suggest that there are at least two broad biological categories of hallucination mechanism: a psychiatric mechanism and a neurodegenerative mechanism. In support, structural signatures of hallucinations in the psychiatric meta-analysis overlap with comparisons of patients to non-disordered controls. For instance, a metaanalysis of GM changes in patients with psychosis compared to healthy controls shows reductions in bilateral insula and anterior cingulate cortex 100 , coinciding with regions identified in the meta-analysis of hallucinations in neurodevelopmental disorders, while thalamic, hippocampal, and occipital GM reductions in PD 101 partly coincide with the changes seen in neurodegenerative hallucinations. The relation between disorder-specific GM changes and hallucination category suggests that hallucinations share networks of brain regions with the pathologies of the disorder in which they are embedded.
Knowledge of the structural correlates of hallucination types may help understand their cognitive phenotypes. For instance, hallucinations are linked to reality monitoring, the cognitive capacity to distinguish between self-generated and external sources of information 102 . Impaired in schizophrenia, reality monitoring is associated with the structure and function of the anterior cingulate cortex 43, 102 . The cingulate gyrus is part of a network involving the IFG, ventral striatum, auditory cortex, right posterior temporal lobe whose functional connectivity is related to the subjective extent to which a hallucination feels real 103 . Indeed, we propose that connectivity is key: together with the insula, the anterior cingulate constitutes nodes of the salience network, dysfunctions in which have been proposed as central to experiencing hallucinations 30 . Structural deficits in the insula in psychosis might also underpin atypical interactions between the DMN and salience network observed in hallucinations 39 . The left STG/MTG have been robustly implicated in the manifestation of AVH 23, 99 , emphasizing the importance of speech perception and processing in hallucinations in schizophrenia spectrum psychosis.
If hallucinations experienced by those with schizophrenia spectrum and bipolar psychosis are an example of a broader mechanism, then we predict that other neurodevelopmental disorders will have similar patterns of associated GM loss. For example, hallucinations have a prevalence of 43% in personality disorder 104 , suggested to be a neurodevelopmental disorder 105 , and are predicted to have a mechanism similar to other psychiatric disorders.
Abnormalities in the occipital cortex in neurodegenerative diseases suggest that deficits in sensory regions contribute to hallucinations of the associated sensory modality since VH are more common in PD than in schizophrenia 19 . Hallucinations in PD and AD were characterized by GM reduction in the thalamus and PHG. The thalamus relays information to higher level processing areas and contributes to working memory maintenance 106 , while the PHG is implicated in processing contextual associations in the service of memory formation and generating expectations about spatial relations 107 . Their involvement supports memory-related processes in hallucinations 28 , though may equally relate to neurodegenerative pathologies. The anterior cingulate was implicated in hallucinations occurring in psychiatric disorders, but not neurodegenerative aetiology. As the anterior cingulate is involved in self-referential processing, this is consistent with the observation that psychotic hallucinations address the individual and vary across continental location and historical time period 14, 108 . Conversely, hallucinations in PD have a more passive quality and form historically stable categories of visual percepts 4 .
Anatomic heterogeneity related to hallucination presence/absence has important consequences for the plurality of treatment options. A specific example is repetitive transcranial magnetic stimulation (rTMS) used to reduce hallucination frequency and severity in schizophrenia, albeit with some reservations 109, 110 . A number of parameters including frequency of stimulation and anatomical site contribute to the outcome of rTMS, and so anatomical heterogeneity is a possible source for the ambiguity of efficacy in therapeutic trials 111 . In general, effective treatment for hallucinations requires an understanding of the underlying mechanism that we suggest varies across diagnosis.
The multimodality of hallucinations is under-documented and under-researched, with <2% of studies included in this review probing hallucinations beyond audition or vision 64 . However, 30-50% of schizophrenia or PD patients report hallucinations in more than one modality 2, 112 : olfactory hallucinations are present in 10-13.7% 51, 113 and tactile sensations frequently co-occur with auditory hallucinations 1 . Despite the dimensionality of hallucinations, many questionnaires and theoretical models target unimodal accounts. Non-clinical individuals who hallucinate or hear voices are receiving increasing interest in scientific research 7 , yet only one study in this review assessed a structural correlate (cortical thickness) of hallucinations in this population 80 .
The prevalence of hallucinations in the general population varies across the lifespan with peaks in early life (<30 years) and between 50-59 years 114 . Results from these meta-analyses predict that early onset of hallucinations will have a pattern of frontotemporal structural deficits similar to psychiatric disorders with neurodevelopmental origins, whilst later onset will show a neurodegenerative pattern of GM change in the occipital cortex, medial temporal lobe and thalamus. In any case, empirical neuroimaging and cognitive research in non-clinical groups and non-dominant modalities is necessary to extend the limits of current knowledge.
As with all meta-analyses, statistical power is restricted by the size of the extant literature, which in neuroimaging the experience of hallucinations remains immature. Despite this, the overall sample size was comparable to other SDM meta-analyses (n=233 H, n=194 NH for psychiatric; n=128 H, n=162 NH for neurodegenerative) 115, 116 . The questionnaires used to assess hallucination status varied in the time frame bounding the hallucination, from within the current week to lifetime history, and few assessed phenomenological characteristics of hallucinations. The latter is potentially confounding as experiential differences may map to different neural substrates 117 . Understanding the neurobiology supporting the content of hallucinations may help in personalizing treatment strategies since hallucination content is related to cognitive profile in PD 118 . The divergence in our meta-analytic findings for psychiatric and neurodegenerative disorders may be partly attributable to differences in modality, since hallucinations experienced in schizophrenia spectrum and bipolar psychosis were predominantly auditory, while those in PD and AD were mostly visual. However, there was no overlap in brain regions identified in the two metaanalyses. Moreover, the reported modalities are partly construed by the questionnaire used. An important question is whether hallucinations of the same modality have common characteristics regardless of diagnosis. Finally, there was also a significant difference in the ages of the participants in the two meta-analyses, although each meta-analysis had its own age-matched control group and thus the comparison between disorders did not capture differences due to aging.
Hallucinations in clinical and non-clinical populations are diverse in content, modality, frequency, and affect, among other dimensions. Though hallucinations have been explored transdiagnostically at the level of phenomenology, little empirical work has made group comparisons of brain structure related to hallucinations. We show that hallucinations in psychiatric disorders have distinct neuroanatomical organization from the pattern observed in neurodegenerative diseases, and in doing so hypothesise at least two structural substrates associated with the hallucinatory experience. This categorical differentiation in the neurobiology of hallucinations is important for optimizing or developing treatment strategies, and makes specific predictions about other disorders, such as personality disorder, and the onset of hallucinations in the general population. The structural networks involved in hallucinations partly coincide with the respective case-control comparisons, and are thus embedded within the broader neuroanatomical phenotype, emphasising the importance of non-hallucinating patient control groups.
Hallucinations are experienced in a variety of mental health contexts and are important phenomena in probing our perception of the external world, but theoretical work has not yet captured the diversity of hallucinations across modalities or diagnoses. By hypothesising at least two mechanisms for hallucinations, we suggest incorporating this plurality in future research. These meta-analyses offer a critical starting point.
